Jagsonpal Pharmaceuticals (India) Today
| JAGSNPHARM | 636.65 9.80 1.52% |
Performance13 of 100
| Odds Of DistressLess than 9
|
Jagsonpal Pharmaceuticals is trading at 636.65 as of the 24th of December 2024. This is a 1.52 percent decrease since the beginning of the trading day. The stock's open price was 646.45. Jagsonpal Pharmaceuticals has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 4th of January 2023 and ending today, the 24th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Jagsonpal Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange. The company has 26.55 M outstanding shares. More on Jagsonpal Pharmaceuticals Limited
Moving together with Jagsonpal Stock
Moving against Jagsonpal Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Jagsonpal Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Jagsonpal Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Jagsonpal Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Jagsonpal Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Jagsonpal Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsJagsonpal Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Jagsonpal Pharmaceuticals' financial leverage. It provides some insight into what part of Jagsonpal Pharmaceuticals' total assets is financed by creditors.
| |||||
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) is traded on National Stock Exchange of India in India and employs 1,025 people. Jagsonpal Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.46 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jagsonpal Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Jagsonpal Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Jagsonpal Pharmaceuticals operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 26.55 M outstanding shares.
Jagsonpal Pharmaceuticals Limited has accumulated about 110.53 M in cash with 351.66 M of positive cash flow from operations.
Check Jagsonpal Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationJagsonpal Pharmaceuticals Limited has a total of 26.55 Million outstanding shares. Jagsonpal Pharmaceuticals retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 76.28 (percent) of Jagsonpal Pharmaceuticals outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Jagsonpal Ownership Details
Jagsonpal Pharmaceuticals Risk Profiles
Although Jagsonpal Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Jagsonpal Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.06 | |||
| Semi Deviation | 2.59 | |||
| Standard Deviation | 4.13 | |||
| Variance | 17.07 |
Jagsonpal Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Jagsonpal Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
Jagsonpal Pharmaceuticals Corporate Management
Elected by the shareholders, the Jagsonpal Pharmaceuticals' board of directors comprises two types of representatives: Jagsonpal Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jagsonpal. The board's role is to monitor Jagsonpal Pharmaceuticals' management team and ensure that shareholders' interests are well served. Jagsonpal Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jagsonpal Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| S Rao | Chief Officer | Profile | |
| Nandita Singh | Company Officer | Profile | |
| Abhishek Joshi | Company Officer | Profile | |
| Bharat Chugh | Assistant Resources | Profile | |
| Ashish Lakhotia | Chief Officer | Profile | |
| Sudeep Paul | Vice Marketing | Profile |
Other Information on Investing in Jagsonpal Stock
Jagsonpal Pharmaceuticals financial ratios help investors to determine whether Jagsonpal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jagsonpal with respect to the benefits of owning Jagsonpal Pharmaceuticals security.